{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:36:57Z","timestamp":1792417017479,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08112"],"award-info":[{"award-number":["23K08112"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49632-7","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:07:32Z","timestamp":1777043252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of TMEM115 as a tumor suppressor gene and clinical prognostic factor that influences TERT expression in pancreatic cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Yu","family":"Sakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyu","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuki","family":"Yagyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Sakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhisa","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Umekita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kugoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"49632_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"49632_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2022.2129884","volume":"36","author":"HM Kolbeinsson","year":"2023","unstructured":"Kolbeinsson, H. M., Chandana, S., Wright, G. P. & Chung, M. Pancreatic cancer: A review of current treatment and novel therapies. J. Invest. Surg. 36, 2129884 (2023).","journal-title":"J. Invest. Surg."},{"key":"49632_CR3","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"49632_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tig.2013.06.007","volume":"29","author":"B Bernardes de Jesus","year":"2013","unstructured":"Bernardes de Jesus, B. & Blasco, M. A. Telomerase at the intersection of cancer and aging. Trends Genet. 29, 513\u2013520 (2013).","journal-title":"Trends Genet."},{"key":"49632_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0092-8674(00)80538-3","volume":"90","author":"M Meyerson","year":"1997","unstructured":"Meyerson, M. et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785\u2013795 (1997).","journal-title":"Cell"},{"key":"49632_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/sj.onc.1205083","volume":"21","author":"K Collins","year":"2002","unstructured":"Collins, K. & Mitchell, J. R. Telomerase in the human organism. Oncogene 21, 564\u2013579 (2002).","journal-title":"Oncogene"},{"key":"49632_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","volume":"33","author":"JW Shay","year":"1997","unstructured":"Shay, J. W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787\u2013791 (1997).","journal-title":"Eur. J. Cancer"},{"key":"49632_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.1115025","volume":"309","author":"I Flores","year":"2005","unstructured":"Flores, I., Cayuela, M. L. & Blasco, M. A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309, 1253\u20131256 (2005).","journal-title":"Science"},{"key":"49632_CR9","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/1873-3468.13084","volume":"592","author":"R Hannen","year":"2018","unstructured":"Hannen, R. & Bartsch, J. W. Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis. FEBS Lett. 592, 2023\u20132031 (2018).","journal-title":"FEBS Lett."},{"key":"49632_CR10","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1038\/onc.2012.441","volume":"32","author":"Z Liu","year":"2013","unstructured":"Liu, Z. et al. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene 32, 4203\u20134213 (2013).","journal-title":"Oncogene"},{"key":"49632_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/genes7080050","volume":"7","author":"MK Ramlee","year":"2016","unstructured":"Ramlee, M. K., Wang, J., Toh, W. X. & Li, S. Transcription regulation of the human telomerase reverse transcriptase (hTERT) gene. Genes (Basel) 7, 50 (2016).","journal-title":"Genes (Basel)"},{"key":"49632_CR12","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","volume":"38","author":"X Yuan","year":"2019","unstructured":"Yuan, X., Larsson, C. & Xu, D. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: Old actors and new players. Oncogene 38, 6172\u20136183 (2019).","journal-title":"Oncogene"},{"key":"49632_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ccr.2009.10.023","volume":"16","author":"DJ Baker","year":"2009","unstructured":"Baker, D. J., Jin, F., Jeganathan, K. B. & van Deursen, J. M. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 16, 475\u2013486 (2009).","journal-title":"Cancer Cell"},{"key":"49632_CR14","doi-asserted-by":"publisher","first-page":"7920","DOI":"10.1158\/0008-5472.CAN-06-0721","volume":"66","author":"ES Calhoun","year":"2006","unstructured":"Calhoun, E. S. et al. Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays. Cancer Res. 66, 7920\u20137928 (2006).","journal-title":"Cancer Res."},{"key":"49632_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.271.5247.350","volume":"271","author":"SA Hahn","year":"1996","unstructured":"Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350\u2013353 (1996).","journal-title":"Science"},{"key":"49632_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/(SICI)1098-2264(199712)20:4<383::AID-GCC10>3.0.CO;2-O","volume":"20","author":"EH Mahlam\u00e4ki","year":"1997","unstructured":"Mahlam\u00e4ki, E. H. et al. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 20, 383\u2013391 (1997).","journal-title":"Genes Chromosomes Cancer"},{"key":"49632_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ng0594-85","volume":"7","author":"JR Gnarra","year":"1994","unstructured":"Gnarra, J. R. et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet. 7, 85\u201390 (1994).","journal-title":"Nat. Genet."},{"key":"49632_CR18","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1158\/0008-5472.CAN-04-4088","volume":"65","author":"A Agathanggelou","year":"2005","unstructured":"Agathanggelou, A., Cooper, W. N. & Latif, F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res. 65, 3497\u20133508 (2005).","journal-title":"Cancer Res."},{"key":"49632_CR19","first-page":"3333","volume":"59","author":"L Ji","year":"1999","unstructured":"Ji, L. et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res. 59, 3333\u20133339 (1999).","journal-title":"Cancer Res."},{"key":"49632_CR20","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1038\/sj.onc.1205421","volume":"21","author":"A Dallol","year":"2002","unstructured":"Dallol, A. et al. Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers. Oncogene 21, 3020\u20133028 (2002).","journal-title":"Oncogene"},{"key":"49632_CR21","doi-asserted-by":"publisher","first-page":"15355","DOI":"10.1038\/s41598-021-94711-6","volume":"11","author":"T Yagyu","year":"2021","unstructured":"Yagyu, T. et al. Human chromosome 3p213 carries TERT transcriptional regulators in pancreatic cancer. Sci Rep. 11, 15355 (2021).","journal-title":"Sci Rep."},{"key":"49632_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/gt.2010.147","volume":"18","author":"Y Kazuki","year":"2011","unstructured":"Kazuki, Y. et al. Refined human artificial chromosome vectors for gene therapy and animal transgenesis. Gene Ther. 18, 384\u2013393 (2011).","journal-title":"Gene Ther."},{"key":"49632_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10577-015-9469-5","volume":"23","author":"N Kouprina","year":"2015","unstructured":"Kouprina, N. & Larionov, V. Recent advances in chromosome engineering. Chromosome Res. 23, 1\u20135 (2015).","journal-title":"Chromosome Res."},{"key":"49632_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s10038-017-0378-7","volume":"63","author":"N Uno","year":"2018","unstructured":"Uno, N., Abe, S., Oshimura, M. & Kazuki, Y. Combinations of chromosome transfer and genome editing for the development of cell\/animal models of human disease and humanized animal models. J. Hum. Genet. 63, 145\u2013156 (2018).","journal-title":"J. Hum. Genet."},{"key":"49632_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1073\/pnas.74.1.319","volume":"74","author":"RE Fournier","year":"1977","unstructured":"Fournier, R. E. & Ruddle, F. H. Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc. Natl. Acad. Sci. U. S. A. 74, 319\u2013323 (1977).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"49632_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s10577-023-09726-8","volume":"31","author":"T Ohira","year":"2023","unstructured":"Ohira, T., Yoshimura, K. & Kugoh, H. Human artificial chromosome carrying 3p21.3-p22.2 region suppresses hTERT transcription in oral cancer cells. Chromosome Res. 31, 17 (2023).","journal-title":"Chromosome Res."},{"key":"49632_CR27","first-page":"2825","volume":"127","author":"YS Ong","year":"2014","unstructured":"Ong, Y. S., Tran, T. H., Gounko, N. V. & Hong, W. TMEM115 is an integral membrane protein of the Golgi complex involved in retrograde transport. J. Cell Sci. 127, 2825\u20132839 (2014).","journal-title":"J. Cell Sci."},{"key":"49632_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/path.2252","volume":"214","author":"AV Ivanova","year":"2008","unstructured":"Ivanova, A. V. et al. Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours. J. Pathol. 214, 46\u201357 (2008).","journal-title":"J. Pathol."},{"key":"49632_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep08201","volume":"5","author":"T Ohira","year":"2015","unstructured":"Ohira, T. et al. miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells. Sci. Rep. 5, 8201 (2015).","journal-title":"Sci. Rep."},{"key":"49632_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2015.10.021","volume":"370","author":"YJ Park","year":"2016","unstructured":"Park, Y. J., Kim, E. K., Bae, J. Y., Moon, S. & Kim, J. Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1. Cancer Lett. 370, 222\u2013231 (2016).","journal-title":"Cancer Lett."},{"key":"49632_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/sj.onc.1206134","volume":"22","author":"GL Carboni","year":"2003","unstructured":"Carboni, G. L. et al. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene 22, 615\u2013626 (2003).","journal-title":"Oncogene"},{"key":"49632_CR32","unstructured":"The Human Protein Atlas. https:\/\/www.proteinatlas.org\/."},{"key":"49632_CR33","doi-asserted-by":"publisher","first-page":"S1187","DOI":"10.1245\/s10434-015-4861-0","volume":"22","author":"O Basturk","year":"2015","unstructured":"Basturk, O. et al. Substaging of lymph node status in resected pancreatic ductal adenocarcinoma has strong prognostic correlations: Proposal for a revised N classification for TNM staging. Ann. Surg. Oncol. 22, S1187\u2013S1195 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"49632_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1097\/SLA.0000000000000814","volume":"261","author":"O Strobel","year":"2015","unstructured":"Strobel, O. et al. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg. 261, 961\u2013969 (2015).","journal-title":"Ann Surg."},{"key":"49632_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8010004","volume":"8","author":"H Kugoh","year":"2015","unstructured":"Kugoh, H., Ohira, T. & Oshimura, M. Studies of tumor suppressor genes via chromosome engineering. Cancers (Basel) 8, 4 (2015).","journal-title":"Cancers (Basel)"},{"key":"49632_CR36","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1128\/MCB.00470-10","volume":"31","author":"DL Qi","year":"2011","unstructured":"Qi, D. L. et al. Identification of PITX1 as a TERT suppressor gene located on human chromosome 5. Mol Cell Biol. 31, 1624\u20131636 (2011).","journal-title":"Mol Cell Biol."},{"key":"49632_CR37","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/hmg\/dds468","volume":"22","author":"Y Kazuki","year":"2013","unstructured":"Kazuki, Y. et al. Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans. Hum Mol Genet. 22, 578\u2013592 (2013).","journal-title":"Hum Mol Genet."},{"key":"49632_CR38","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1001\/jama.1995.03520310056030","volume":"273","author":"J Hung","year":"1995","unstructured":"Hung, J. et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273, 1908 (1995).","journal-title":"JAMA"},{"key":"49632_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0065-230X(08)60096-2","volume":"71","author":"K Kok","year":"1997","unstructured":"Kok, K., Naylor, S. L. & Buys, C. H. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res. 71, 27\u201392 (1997).","journal-title":"Adv Cancer Res."},{"key":"49632_CR40","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1038\/sj.onc.1210547","volume":"26","author":"LB Hesson","year":"2007","unstructured":"Hesson, L. B., Cooper, W. N. & Latif, F. Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 26, 7283\u20137301 (2007).","journal-title":"Oncogene"},{"key":"49632_CR41","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.onc.1206243","volume":"22","author":"A Agathanggelou","year":"2003","unstructured":"Agathanggelou, A. et al. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 22, 1580\u20131588 (2003).","journal-title":"Oncogene"},{"key":"49632_CR42","doi-asserted-by":"publisher","first-page":"19932","DOI":"10.1073\/pnas.0805003105","volume":"105","author":"TV Sharp","year":"2008","unstructured":"Sharp, T. V. et al. The chromosome 3p213-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development. Proc Natl Acad Sci U S A. 105, 19932\u201319937 (2008).","journal-title":"Proc Natl Acad Sci U S A."},{"key":"49632_CR43","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1158\/0008-5472.CAN-03-3869","volume":"64","author":"J Li","year":"2004","unstructured":"Li, J. et al. Functional characterization of the candidate tumor suppressor gene NPRL2\/G21 located in 3p213C. Cancer Res. 64, 6438\u20136443 (2004).","journal-title":"Cancer Res."},{"key":"49632_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/2041-9414-1-6","volume":"1","author":"S Abe","year":"2010","unstructured":"Abe, S. et al. Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering. Genome Integr. 1, 6 (2010).","journal-title":"Genome Integr."},{"key":"49632_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bbrc.2015.09.119","volume":"466","author":"S Nishio","year":"2015","unstructured":"Nishio, S. et al. Repression of hTERT transcription by the introduction of chromosome 3 into human oral squamous cell carcinoma. Biochem Biophys Res Commun. 466, 755\u2013759 (2015).","journal-title":"Biochem Biophys Res Commun."},{"key":"49632_CR46","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1474-9726.2011.00718.x","volume":"10","author":"NM Gomes","year":"2011","unstructured":"Gomes, N. M. et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination. Aging Cell 10, 761\u2013768 (2011).","journal-title":"Aging Cell"},{"key":"49632_CR47","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/s41388-020-01405-w","volume":"39","author":"AN Guterres","year":"2020","unstructured":"Guterres, A. N. & Villanueva, J. Targeting telomerase for cancer therapy. Oncogene 39, 5811\u20135824 (2020).","journal-title":"Oncogene"},{"key":"49632_CR48","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41417-024-00768-6","volume":"31","author":"S Shou","year":"2024","unstructured":"Shou, S. et al. Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase. Cancer Gene Ther. 31, 1292\u20131305 (2024).","journal-title":"Cancer Gene Ther."},{"key":"49632_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11605-007-0383-9","volume":"12","author":"Y Hashimoto","year":"2008","unstructured":"Hashimoto, Y. et al. Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas. J. Gastrointest. Surg. 12, 17\u201328 (2008) (discussion 28\u201329).","journal-title":"J. Gastrointest. Surg."},{"key":"49632_CR50","doi-asserted-by":"publisher","first-page":"15121","DOI":"10.1074\/jbc.M113.470047","volume":"288","author":"Z Ma","year":"2013","unstructured":"Ma, Z., Vocadlo, D. J. & Vosseller, K. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-\u03baB activity in pancreatic cancer cells. J Biol Chem. 288, 15121\u201315130 (2013).","journal-title":"J Biol Chem."},{"key":"49632_CR51","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1038\/onc.2010.41","volume":"29","author":"SA Caldwell","year":"2010","unstructured":"Caldwell, S. A. et al. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29, 2831\u20132842 (2010).","journal-title":"Oncogene"},{"key":"49632_CR52","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bbadis.2011.01.009","volume":"1812","author":"W Mi","year":"2011","unstructured":"Mi, W. et al. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta. 1812, 514\u2013519 (2011).","journal-title":"Biochim Biophys Acta."},{"key":"49632_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1247\/csf.16023","volume":"42","author":"M Taniguchi","year":"2017","unstructured":"Taniguchi, M. & Yoshida, H. TFE3, HSP47, and CREB3 pathways of the mammalian Golgi stress response. Cell Struct. Funct. 42, 27\u201336 (2017).","journal-title":"Cell Struct. Funct."},{"key":"49632_CR54","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.bbagen.2019.04.002","volume":"1863","author":"V Makwana","year":"2019","unstructured":"Makwana, V., Ryan, P., Patel, B., Dukie, S. A. & Rudrawar, S. Essential role of O-GlcNAcylation in stabilization of oncogenic factors. Biochimica et Biophysica Acta (BBA) 1863, 1302\u20131317 (2019).","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"49632_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.canlet.2014.04.014","volume":"356","author":"JP Singh","year":"2015","unstructured":"Singh, J. P., Zhang, K., Wu, J. & Yang, X. O-GlcNAc signaling in cancer metabolism and epigenetics. Cancer Lett. 356, 244\u2013250 (2015).","journal-title":"Cancer Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49632-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49632-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49632-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:02:56Z","timestamp":1781827376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49632-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49632"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49632-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The IHC staining protocol and ethics using tissue samples from PC patients were approved by the Tottori University Ethical Board (approval number: 24A017). All patients provided written informed consent for pathological analysis. All study procedures were conducted in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"19056"}}